Sleep-Wake Disorders Unit, Department of Neurology, Gui-de-Chauliac Hospital, CHU, Montpellier, France.
INM, University Montpellier, INSERM, Montpellier, France.
J Sleep Res. 2024 Feb;33(1):e13964. doi: 10.1111/jsr.13964. Epub 2023 Jun 20.
Sleep disturbances after ischaemic stroke include alterations of sleep architecture, obstructive sleep apnea, restless legs syndrome, daytime sleepiness and insomnia. Our aim was to explore their impacts on functional outcomes at month 3 after stroke, and to assess the benefit of continuous positive airway pressure in patients with severe obstructive sleep apnea. Ninety patients with supra-tentorial ischaemic stroke underwent clinical screening for sleep disorders and polysomnography at day 15 ± 4 after stroke in a multisite study. Patients with severe obstructive apnea (apnea-hypopnea index ≥ 30 per hr) were randomized into two groups: continuous positive airway pressure-treated and sham (1:1 ratio). Functional independence was assessed with the Barthel Index at month 3 after stroke in function of apnea-hypopnea index severity and treatment group. Secondary objectives were disability (modified Rankin score) and National Institute of Health Stroke Scale according to apnea-hypopnea index. Sixty-one patients (71.8 years, 42.6% men) completed the study: 51 (83.6%) had obstructive apnea (21.3% severe apnea), 10 (16.7%) daytime sleepiness, 13 (24.1%) insomnia, 3 (5.7%) depression, and 20 (34.5%) restless legs syndrome. Barthel Index, modified Rankin score and Stroke Scale were similar at baseline and 3 months post-stroke in the different obstructive sleep apnea groups. Changes at 3 months in those three scores were similar in continuous positive airway pressure versus sham-continuous positive airway pressure patients. In patients with worse clinical outcomes at month 3, mean nocturnal oxygen saturation was lower whereas there was no association with apnea-hypopnea index. Poorer outcomes at 3 months were also associated with insomnia, restless legs syndrome, depressive symptoms, and decreased total sleep time and rapid eye movement sleep.
缺血性脑卒中后的睡眠障碍包括睡眠结构改变、阻塞性睡眠呼吸暂停、不宁腿综合征、日间嗜睡和失眠。我们的目的是探讨它们在脑卒中后 3 个月时对功能结局的影响,并评估严重阻塞性睡眠呼吸暂停患者持续气道正压通气的获益。90 例幕上缺血性脑卒中患者在多中心研究中于卒中后 15 ± 4 天接受了睡眠障碍的临床筛查和多导睡眠图检查。将严重阻塞性呼吸暂停(呼吸暂停低通气指数≥30 次/小时)患者随机分为两组:持续气道正压通气治疗组和假治疗组(1:1 比例)。根据呼吸暂停低通气指数严重程度和治疗组,在脑卒中后 3 个月时使用巴氏指数评估患者的功能独立性。次要终点为残疾(改良 Rankin 评分)和根据呼吸暂停低通气指数的国立卫生研究院卒中量表。61 例患者(71.8 岁,42.6%为男性)完成了研究:51 例(83.6%)存在阻塞性呼吸暂停(21.3%为严重呼吸暂停),10 例(16.7%)日间嗜睡,13 例(24.1%)失眠,3 例(5.7%)抑郁,20 例(34.5%)不宁腿综合征。在不同的阻塞性睡眠呼吸暂停组中,基线和脑卒中后 3 个月时巴氏指数、改良 Rankin 评分和卒中量表相似。在持续气道正压通气组与假持续气道正压通气组中,这三个评分在 3 个月时的变化相似。在 3 个月时临床结局较差的患者中,夜间氧饱和度平均值较低,但与呼吸暂停低通气指数无关。3 个月时较差的结局还与失眠、不宁腿综合征、抑郁症状以及总睡眠时间和快速动眼睡眠减少有关。